TLX Annual Cash & Cash Equivalents
$83.96 M
+$4.82 M+6.09%
01 December 2023
Summary:
As of January 21, 2025, TLX annual cash & cash equivalents is $83.96 million, with the most recent change of +$4.82 million (+6.09%) on December 1, 2023. During the last 3 years, it has risen by +$24.03 million (+40.10%). TLX annual cash & cash equivalents is now at all-time high.TLX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TLX Quarterly Cash And Cash Equivalents
$79.43 M
-$4.53 M-5.40%
01 June 2024
Summary:
As of January 21, 2025, TLX quarterly cash and cash equivalents is $79.43 million, with the most recent change of -$4.53 million (-5.40%) on June 1, 2024. Over the past year, it has stayed the same.TLX quarterly cash and cash equivalents is now -8.90% below its all-time high of $87.20 million, reached on June 1, 2023.TLX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TLX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.1% | 0.0% |
| 3 y3 years | +40.1% | -5.8% |
| 5 y5 years | +362.5% | +154.4% |
TLX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +425.6% | -8.9% | +397.2% |
| 5 y | 5-year | at high | +425.6% | -8.9% | +397.2% |
| alltime | all time | at high | +425.6% | -8.9% | +1017.9% |
Telix Pharmaceuticals Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $79.43 M(-5.4%) |
| Dec 2023 | $83.96 M(+6.1%) | $83.96 M(-3.7%) |
| June 2023 | - | $87.20 M(+10.2%) |
| Dec 2022 | $79.14 M(+395.4%) | $79.14 M(-6.2%) |
| June 2022 | - | $84.34 M(+428.0%) |
| Dec 2021 | $15.97 M(-73.3%) | $15.97 M(-57.1%) |
| June 2021 | - | $37.28 M(-37.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $59.93 M(+91.9%) | $59.93 M(+257.8%) |
| June 2020 | - | $16.75 M(-46.4%) |
| Dec 2019 | $31.22 M(+72.0%) | $31.22 M(+339.4%) |
| June 2019 | - | $7.11 M(-60.9%) |
| Dec 2018 | $18.15 M(-52.3%) | $18.15 M(-6.3%) |
| June 2018 | - | $19.37 M |
| Dec 2017 | $38.03 M | - |
FAQ
- What is Telix Pharmaceuticals Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Telix Pharmaceuticals Limited?
- What is Telix Pharmaceuticals Limited annual cash & cash equivalents year-on-year change?
- What is Telix Pharmaceuticals Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Telix Pharmaceuticals Limited?
- What is Telix Pharmaceuticals Limited quarterly cash and cash equivalents year-on-year change?
What is Telix Pharmaceuticals Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of TLX is $83.96 M
What is the all time high annual cash & cash equivalents for Telix Pharmaceuticals Limited?
Telix Pharmaceuticals Limited all-time high annual cash & cash equivalents is $83.96 M
What is Telix Pharmaceuticals Limited annual cash & cash equivalents year-on-year change?
Over the past year, TLX annual cash & cash equivalents has changed by +$4.82 M (+6.09%)
What is Telix Pharmaceuticals Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TLX is $79.43 M
What is the all time high quarterly cash and cash equivalents for Telix Pharmaceuticals Limited?
Telix Pharmaceuticals Limited all-time high quarterly cash and cash equivalents is $87.20 M
What is Telix Pharmaceuticals Limited quarterly cash and cash equivalents year-on-year change?
Over the past year, TLX quarterly cash and cash equivalents has changed by $0.00 (0.00%)